New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 24, 2013
11:38 EDTSCSS, SRPT, NFLX, OSTK, FIREOptions with decreasing implied volatility: SRPT FIRE NFLX SCSS OSTK
News For SRPT;FIRE;NFLX;SCSS;OSTK From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 >>
August 24, 2015
13:54 EDTSRPTFly Watch: Sarepta upgraded ahead of FDA deadline on DMD drug
The 60-day FDA review period for Sarepta's (SRPT) rolling NDA submission for its Duchenne muscular dystrophy drug eteplirsen ends tomorrow, Tuesday, August 25. Piper Jaffray is among research firms taking a bullish stance on the stock ahead of tomorrow's deadline. BACKGROUND: Eteplirsen is an "exon skipping" treatment that attempts to bypass genetic mutations to allow improved functioning of the affected gene. On August 21, Sarepta announced that the FDA granted a rare pediatric disease designation for eteplirsen, in addition to its previous orphan designation and fast track status. Piper Jaffray's Edward Tenthoff noted today that the drug could see a February 2016 PDUFA date, potentially yielding "blockbuster sales" for the company. Importantly, BioMarin's (BMRN) drisapersen is slightly ahead of eteplirsen's approval process with a December 27 PDUFA date, posing a potential competitive risk for Sarepta. PDUFA dates are FDA deadlines for approving new drugs, normally coming within 6 or 10 months of an NDA acceptance depending on the drug's priority status. ANALYST TAKE: Tenthoff stated in note to investors this morning that he expects the Food and Drug Administration to accept the New Drug Application for Sarepta's eteplirsen at the end of its 60-day review period tomorrow. Additionally, Tenthoff sees a joint advisory committee for eteplirsen and the similar drisapersen from BioMarin on November 23-24. On May 19, Sarepta said it held pre-NDA meetings with the FDA, and Piper Jaffray said it believes the company has now met all of the agency's information requests. The analyst upgraded Sarepta to Overweight from Neutral and hiked his price target to $48 from $28 and now values eteplirsen at $1.3B, up from $919M previously. PRICE ACTION: Shares of Sarepta Therapeutics are up roughly 1% in intraday trading to $34.21. The stock jumped about 60% on May 20 after the company announced its mid-year NDA plans for eteplirsen. BioMarin shares, meanwhile, are down 2% to $123.59 this afternoon.
13:46 EDTNFLXNetflix turns negative on the session, levels to watch
Subscribe for More Information
09:45 EDTSRPTOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: Bank of America (BAC) upgraded to Outperform from Market Perform at Keefe Bruyette... Bristol-Myers (BMY) upgraded to Neutral from Underweight at Piper Jaffray... Chevron (CVX) upgraded to Neutral from Underperform at BofA/Merrill... Abercrombie & Fitch (ANF) upgraded to Overweight from Neutral... Nike (NKE) upgraded to Outperform from Market Perform at Telsey Advisory... DreamWorks (DWA) upgraded to Buy from Neutral at B. Riley... Caesarstone (CSTE) upgraded to Overweight from Equal Weight at Barclays... TransAlta (TAC) upgraded to Outperform from Market Perform at BMO Capital... Sarepta (SRPT) upgraded to Overweight from Neutral at Piper Jaffray... AutoZone (AZO) upgraded to Buy from Neutral at BofA/Merrill... Royal Dutch Shell (RDS.A) upgraded to Buy from Hold at Jefferies... Allscripts (MDRX) upgraded to Buy from Hold at Argus... China Unicom (CHU) upgraded to Buy from Hold at Jefferies... Ross Stores (ROST) upgraded to Buy from Neutral at Buckingham.
09:36 EDTNFLXActive equity options trading on open
Active equity options trading on open: AAPL FB BAC NFLX
09:21 EDTNFLXNetflix plunges over 12% in pre-market
Subscribe for More Information
08:51 EDTNFLXNetflix confirms partnership with SoftBank ahead of Japan launch
SoftBank Corp (SFTBF) and Netflix (NFLX) confirmed that SoftBank, among Japanese telecommunications companies, will exclusively offer a fully integrated Netflix experience, including billing, when Netflix Japan launches on September 2. Under the agreement, SoftBank customers will be able to sign up for Netflix at SoftBank Shops, major electronics retailers, via the SoftBank website and via SoftBank call centers without filling out payment information, with Netflix's monthly fee added to their bill. In addition, SoftBank will begin pre-installing the Netflix app on its smartphones for sale after October 2015.
08:28 EDTNFLXNetflix volatility elevated
Subscribe for More Information
08:05 EDTNFLXFacebook Netflix TubeMogul best Internet pullback opportunities,says Oppenheimer
Oppenheimer sees Facebook (FB) Netflix (NFLX) and TubeMogul (TUBE) as providing the best buying opportunities among Internet stocks. The firm notes that the growth of Facebook's usage minutes fell to 17% year-over-year in July from a 20% increase in June and a 21% increase in May. However, the firm notes that the company maintained its 21% share of time on mobile devices. The firm thinks that the company's earnings could be boosted in the near-term by the launch of performance-based ads on Instagram. Oppenheimer notes that Netflix has risks from U.S. dollar appreciation and investors' skepticism towards stocks whose value is based on expected long-term growth. TubeMogul could be hurt by perceived risks to global macro growth, according to the firm.Despite these risks, the firm thinks that Facebook's stock could rise 27% above its $110 price target. It believes that Netflix's stock could jump 15% above its $125 price target and it thinks that TubeMogul could surpass its $19 price target by 83%.
06:50 EDTSRPTSarepta upgraded to Overweight from Neutral at Piper Jaffray
Subscribe for More Information
06:30 EDTNFLXDiscovery exec: Group in 'hand to hand combat' with Netflix, Guardian says
Subscribe for More Information
06:07 EDTNFLXNetflix partners with SoftBank ahead of Japan launch, Japan Times reports
Subscribe for More Information
August 21, 2015
16:01 EDTNFLXOptions Update; August 21, 2015
Subscribe for More Information
13:50 EDTNFLXOn The Fly: Weekly technical notes, Gold, S&P 500, Germany, China, Energy
Subscribe for More Information
12:14 EDTNFLXStocks with call strike movement; FB NFLX
Facebook (FB) November 110 call option implied volatility increased 8% to 38, Netflix (NFLX) December 130 call option implied volatility increased 4% to 54 according to iVolatility.
10:36 EDTSRPTOptions with increasing implied volatility
Options with increasing implied volatility: PTCT UVXY VIX VXX SVXXY SRPT TZA UPRO VNR SPXU
09:42 EDTNFLXNetflix falls, levels to watch
Shares were last at $106.21, down by more than 5.5%. At that price the low of the day at $104.92 would be next support, and then $101.09. Resistance is at $109.86. The move today is taking place under the 30-day moving average, which was longer-term uptrend support.
09:34 EDTNFLXActive equity options trading on open
Active equity options trading on open: AAPL FB BAC NFLX DIS TSLA TWTR
09:27 EDTNFLXNetflix volatility increases as shares pull back
Subscribe for More Information
08:32 EDTSRPTSarepta says FDA grants rare pediatric disease designation for Eteplirsen
Subscribe for More Information
05:47 EDTNFLXStocks with implied volatility movement; NFLX FB
Subscribe for More Information
1 | 2 | 3 | 4 | 5 >>

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use